Skip to content
10-Q

Quarterly Report

Amgen Inc. AMGN

0000318154-24-000044

← back to feed
Filed
Oct 31, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Oct 25, 2024 537.53M sh
Long Term Debt Q3 2024 · Sep 30, 2024 $56.85B
Long Term Debt Q3 2024 · Dec 31, 2023 $63.17B
Cash And Equivalents Q3 2024 · Sep 30, 2024 $9.01B
Cash And Equivalents Q3 2024 · Dec 31, 2023 $10.94B
Current Liabilities Q3 2024 · Sep 30, 2024 $20.31B
Current Liabilities Q3 2024 · Dec 31, 2023 $18.39B
Current Assets Q3 2024 · Sep 30, 2024 $26.77B
Current Assets Q3 2024 · Dec 31, 2023 $30.33B
Total Assets Q3 2024 · Sep 30, 2024 $90.88B
Total Assets Q3 2024 · Dec 31, 2023 $97.15B
Net Income Q3 2024 · Jun 30, 2024 $746M
Net Income Q3 2024 · Mar 31, 2024 −$113M
Net Income Q3 2024 · Sep 30, 2023 $1.73B
Net Income Q3 2024 · Sep 30, 2023 $5.95B
Net Income Q3 2024 · Jun 30, 2023 $1.38B
Net Income Q3 2024 · Mar 31, 2023 $2.84B
Stockholders Equity Q3 2024 · Mar 31, 2024 $5.02B
Stockholders Equity Q3 2024 · Sep 30, 2023 $7.66B
Stockholders Equity Q3 2024 · Jun 30, 2023 $6.78B
Stockholders Equity Q3 2024 · Mar 31, 2023 $5.35B
Stockholders Equity Q3 2024 · Dec 31, 2022 $3.66B
Shares Diluted Q3 2024 · Sep 30, 2023 538M sh
Shares Diluted Q3 2024 · Sep 30, 2023 538M sh
Dividends Paid Q3 2024 · Sep 30, 2023 $3.42B
Capex Q3 2024 · Sep 30, 2023 $863M
Operating Cash Flow Q3 2024 · Sep 30, 2023 $7.93B
Eps Diluted Q3 2024 · Sep 30, 2023 $3.22
Eps Diluted Q3 2024 · Sep 30, 2023 $11.06
Eps Basic Q3 2024 · Sep 30, 2023 $3.23
Eps Basic Q3 2024 · Sep 30, 2023 $11.12
Sga Expense Q3 2024 · Sep 30, 2023 $1.35B
Sga Expense Q3 2024 · Sep 30, 2023 $3.91B
Operating Income Q3 2024 · Sep 30, 2023 $2.02B
Operating Income Q3 2024 · Sep 30, 2023 $6.63B
Cost Of Revenue Q3 2024 · Sep 30, 2023 $1.81B
Cost Of Revenue Q3 2024 · Sep 30, 2023 $5.34B
Revenue Q3 2024 · Sep 30, 2023 $6.9B
Revenue Q3 2024 · Sep 30, 2023 $19.99B